Analysts expect Encompass Health Corp (NYSE:EHC) to report earnings of $0.97 per share for the current quarter, according to Zacks. Seven analysts have issued estimates for Encompass Health’s earnings, with estimates ranging from $0.95 to $1.00. Encompass Health posted earnings per share of $0.99 in the same quarter last year, which suggests a negative year over year growth rate of 2%. The business is scheduled to issue its next earnings results after the market closes on Monday, July 29th.

According to Zacks, analysts expect that Encompass Health will report full year earnings of $3.80 per share for the current year, with EPS estimates ranging from $3.75 to $3.88. For the next year, analysts expect that the business will post earnings of $3.84 per share, with EPS estimates ranging from $3.57 to $4.00. Zacks Investment Research’s EPS averages are a mean average based on a survey of research firms that that provide coverage for Encompass Health.

Encompass Health (NYSE:EHC) last announced its earnings results on Thursday, April 25th. The company reported $1.04 earnings per share for the quarter, topping analysts’ consensus estimates of $0.89 by $0.15. Encompass Health had a return on equity of 23.82% and a net margin of 7.14%. The firm had revenue of $1.12 billion for the quarter, compared to the consensus estimate of $1.11 billion.

A number of equities research analysts recently commented on the stock. BMO Capital Markets initiated coverage on shares of Encompass Health in a report on Thursday, June 27th. They issued an “outperform” rating and a $72.00 price target on the stock. Barclays raised shares of Encompass Health from an “equal weight” rating to an “overweight” rating and boosted their target price for the company from $68.00 to $70.00 in a report on Thursday, May 30th. One analyst has rated the stock with a hold rating and seven have issued a buy rating to the company. Encompass Health has a consensus rating of “Buy” and an average target price of $78.00.

Shares of NYSE EHC traded up $0.11 during midday trading on Friday, reaching $65.51. The company’s stock had a trading volume of 910,983 shares, compared to its average volume of 816,849. The company has a debt-to-equity ratio of 1.71, a current ratio of 0.89 and a quick ratio of 0.89. The firm has a market cap of $6.40 billion, a PE ratio of 18.05, a P/E/G ratio of 2.17 and a beta of 0.81. The firm has a 50 day moving average price of $61.89. Encompass Health has a 12-month low of $56.74 and a 12-month high of $82.46.

The firm also recently announced a quarterly dividend, which was paid on Monday, July 15th. Shareholders of record on Monday, July 1st were issued a dividend of $0.27 per share. The ex-dividend date was Friday, June 28th. This represents a $1.08 dividend on an annualized basis and a yield of 1.65%. Encompass Health’s payout ratio is 29.75%.

Encompass Health Company Profile

Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates through two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.

Featured Story: The primary rules of Elliott Wave theory

Get a free copy of the Zacks research report on Encompass Health (EHC)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with's FREE daily email newsletter.